-+ 0.00%
-+ 0.00%
-+ 0.00%

BIPROGY (TSE:8056) Stock Slides As Profit Squeeze Sharpens

Simply Wall St·08/06/2026 10:22:54
Listen to the news

BIPROGY walked into this earnings season with a reputation for steady, high quality profits and a P/E below many Japanese IT peers. Yet the stock sits at ¥4,167 and has drifted lower over the past week and month. The fresh Q1 2027 numbers put the focus squarely on profit pressure. Basic earnings per share of ¥46.42 and net income of ¥4,484m sit well below the recent quarterly run rate. For you as an investor, the story now hinges on whether this margin squeeze is a blip or the start of a tougher phase.

Love BIPROGY’s history of steady profits but concerned this latest margin squeeze might not be an isolated quarter? Check out the list of solid balance sheet and fundamentals stocks (40 results).

Q1 2027 Earnings Summary

  • Revenue (Q1 2027 vs Q1 2026): ¥91,464m vs. ¥102,566m (decline of about 10.8%)
  • Net Income (Excl. Extra Items, Q1 2027 vs Q1 2026): ¥4,484m vs. ¥7,661.5m (decline of about 41.5%)
  • Basic EPS (Q1 2027 vs Q1 2026): ¥46.42 vs. ¥78.30 (decline of about 40.7%)
  • Trailing Twelve Month Net Profit Margin (Q1 2027 vs Q1 2026): 7.0% vs. 6.9% (slight improvement)

Prefer visual charts instead of another wall of earnings tables and ratios? See BIPROGY’s full financial picture, including a clear view of its recent profit trends and margins, in the interactive company report for BIPROGY.

TSE:8056 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:8056 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

BIPROGY’s Defensive Story Meets Mixed Support

BIPROGY is often framed as a defensive digital backbone because of its role across essential sectors. The latest quarter does offer some support for that view. The trailing twelve month net profit margin is roughly stable at 7.0% compared with 6.9%. That suggests the broader profitability profile has not broken down even though this quarter is weaker. For investors who like the idea of a solid IT services business with long relationships, the margin stability over twelve months still points to a business model that can absorb some pressure.

Revenue Drop Puts Pressure On The Transformation Pitch

The bear case around BIPROGY focuses on margin pressure and the risk that it behaves more like a mature contractor than a growth driven transformer. The Q1 2027 numbers lend weight to those worries. Revenue fell about 10.8% year on year and net income excluding extra items declined about 41.5%. Basic EPS also moved in the same direction. Those moves sit alongside a share price that is down over the past 7, 30 and 90 days, which shows investors reacting cautiously to this earnings reset.

After a revenue drop of 10.8% and a roughly 41.5% fall in net income, it is fair to ask if this is a short term reset or an early sign of deeper issues in BIPROGY’s earnings quality, contract pipeline or cost base. Review our independent risk analysis for BIPROGY which shows 1 important warning sign

Stay Ahead With BIPROGY Insights

If BIPROGY’s recent revenue and profit pressure has you watching for a better entry point, register for free with Simply Wall St and add it to a Watchlist to track share price moves against fair value and earnings updates. Once you decide to invest, use the Portfolio Command Center to cut through market noise and focus on the key developments that matter to your holdings. For a broader view on BIPROGY and similar stocks, turn to the Community to see how other investors are thinking about the same risks and potential catalysts. This way you can spot hidden strengths or early warning signs sooner and stay a step ahead of the market.

Seeking Alternatives Beyond BIPROGY Now

Fresh ideas move first. Stocks with quiet momentum often break out while everyone stays caught on yesterday’s headlines. Scan curated opportunities under the radar for now and act promptly.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.